Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
INmune Bio, Inc. (INMB) Q2 2022 Earnings Call Transcript
Motley Fool Transcribing
|
Aug 4, 2022
INMB earnings call for the period ending June 30, 2022.
INmune Bio, Inc. (INMB) Q1 2022 Earnings Call Transcript
Motley Fool Transcribing
|
May 6, 2022
INMB earnings call for the period ending March 31, 2022.
INmune Bio, Inc. (INMB) Q4 2021 Earnings Call Transcript
Motley Fool Transcribing
|
Mar 4, 2022
INMB earnings call for the period ending December 31, 2021.
INmune Bio, Inc. (INMB) Q3 2021 Earnings Call Transcript
Motley Fool Transcribing
|
Nov 4, 2021
INMB earnings call for the period ending September 30, 2021.
I-MAB (IMAB) Q2 2021 Earnings Call Transcript
Motley Fool Transcribers
|
Aug 31, 2021
IMAB earnings call for the period ending June 30, 2021.
INmune Bio, Inc. (INMB) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
|
May 6, 2021
INMB earnings call for the period ending March 31, 2021.
IMab ADR (IMAB) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
|
Mar 29, 2021
IMAB earnings call for the period ending December 31, 2020.
INmune Bio, Inc. (INMB) Q4 2020 Earnings Call Transcript
Motley Fool Transcribing
|
Mar 5, 2021
INMB earnings call for the period ending December 31, 2020.
Why INmune Bio Stock Soared Then Sank Today
Keith Speights
|
Jan 21, 2021
The wild ride for the biotech stock started with its announcement of results from a phase 1b study.
AbbVie Partners With I-Mab for Cancer Drug
Jim Crumly
|
Sep 4, 2020
The deal could be the largest-ever out-licensing agreement by a Chinese biotech.
View More Articles